The State Bank of India (SBI) board has approved a capital infusion of Rs 3,004 crore by the government through preferential allotment of shares. The infusion would help the bank shore up its tier-I capital. As of September-end, the bank’s capital adequacy ratio was 12.63 per cent, including tier-I capital of 8.97 per cent.
The government’s equity infusion is part of enhancing the bank's capital base under Basel-III norms, effective April 1. On January 10, the government had cleared first tranche of the Rs 12,517-crore capital an infusion into public sector banks. The Cabinet had approved infusion of Rs 3,004 crore for SBI.
Yesterday, the SBI stock closed at Rs 2,491.20 on the BSE, a rise of 0.93 per cent over the previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app